Therapeutic neovascularization by the implantation of autologous mononuclear cells in patients with connective tissue diseases

Current Pharmaceutical Design

Volumn 15, Issue 24, 2009, Pages 2778-2783

  Takahashi, Masafumi ^a   Izawa, Atsushi ^a   Ishigatsubo, Yoshiaki ^b   Fujimoto, Kazuteru ^c   Miyamoto, Masaaki ^d   Horie, Takashi ^e   Aizawa, Yoshifusa ^f   Amano, Jun ^g   Minota, Seiji ^h   Murohara, Toyoaki ⁱ   Matsubara, Hiroaki ^j   Ikeda, Uichi ^a  

^a SHINSHU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c NATIONAL HOSPITAL ORGANIZATION KUMAMOTO MEDICAL CENTER   (Japan)

^d NIPPON MEDICAL SCHOOL   (Japan)

^e SAPPORO HOKUYU HOSPITAL   (Japan)

^f NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^g SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^h JICHI MEDICAL UNIVERSITY   (Japan)

ⁱ NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^j KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

more..

Author keywords

Angiogenesis; Connective tissue disease; EPCs; Ischemia; Mononuclear cells; Scleroderma; Vasculopathy

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CD133 ANTIGEN; CD34 ANTIGEN; INTERLEUKIN 1BETA; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ARTERY INTIMA PROLIFERATION; ATHEROSCLEROSIS; AUTOTRANSPLANTATION; CELL PROLIFERATION; CELL THERAPY; CLINICAL TRIAL; CONNECTIVE TISSUE DISEASE; CYTOKINE RELEASE; DISEASE EXACERBATION; ENDOTHELIUM CELL; HEMATOPOIETIC STEM CELL; HUMAN; LIMB ISCHEMIA; MONONUCLEAR CELL; PARACRINE SIGNALING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SMALL VESSEL VASCULITIS; SUDDEN DEATH; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; TREATMENT RESPONSE; VASCULAR DISEASE; ANIMAL; CYTOLOGY; ISCHEMIA; LIMB; TRANSPLANTATION; VASCULARIZATION;

ANIMALS; ANTIGENS, CD34; CONNECTIVE TISSUE DISEASES; ENDOTHELIAL CELLS; EXTREMITIES; HUMANS; ISCHEMIA; LEUKOCYTES, MONONUCLEAR; NEOVASCULARIZATION, PHYSIOLOGIC; TRANSPLANTATION, AUTOLOGOUS;

EID: 70350503711     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161209788923813     Document Type: Review

References (55)

1. Udelson JE, Dilsizian V, Laham RJ, Chronos N, Vansant J, Blais M, et al. Therapeutic angiogenesis with recombinant fibroblast growth factor-2 improves stress and rest myocardial perfusion abnormalities in patients with severe symptomatic chronic coronary artery disease. Circulation 2000; 102: 1605-1610 (Pubitemid 30736923)
2. Schumacher B, Pecher P, von Specht BU, Stegmann T. Induction of neoangiogenesis in ischemic myocardium by human growth factors: first clinical results of a new treatment of coronary heart disease. Circulation 1998; 97: 645-650 (Pubitemid 28090957)
3. Losordo DW, Vale PR, Hendel RC, Milliken CE, Fortuin FD, Cummings N, et al. Phase 1/2 placebo-controlled, double-blind, dose-escalating trial of myocardial vascular endothelial growth factor 2 gene transfer by catheter delivery in patients with chronic myocardial ischemia. Circulation 2002; 105: 2012-2018 (Pubitemid 34465261)
4. Baumgartner I, Pieczek A, Manor O, Blair R, Kearney M, Walsh K, et al. Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation 1998; 97: 1114-1123 (Pubitemid 28152883)
5. Tateishi-Yuyama E, Matsubara H, Murohara T, Ikeda U, Shintani S, Masaki H, et al. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet 2002; 360: 427-435 (Pubitemid 34884192)
6. Jia L, Takahashi M, Yoshioka T, Morimoto H, Ise H, Ikeda U. Therapeutic potential of endothelial progenitor cells for cardiovascular diseases. Curr Vasc Pharmacol 2006; 4: 59-65. (Pubitemid 46785182)
7. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 275: 964-967 (Pubitemid 27087709)
8. Olin JW. Thromboangiitis obliterans (Buerger's disease). N Engl J Med 2000; 343: 864-869
9. Felipe Flores-Suarez L, Alarcon-Segovia D. Vasculitis in the connective tissue diseases. Curr Rheumatol Rep 2000; 2: 396-401.
10. Durdu S, Akar AR, Arat M, Sancak T, Eren NT, Ozyurda U. Autologous bone-marrow mononuclear cell implantation for patients with Rutherford grade II-III thromboangiitis obliterans. J Vasc Surg 2006; 44: 732-739 (Pubitemid 44441783)
11. Motukuru V, Suresh KR, Vivekanand V, Raj S, Girija KR. Therapeutic angiogenesis in Buerger's disease (thromboangiitis obliterans) patients with critical limb ischemia by autologous transplantation of bone marrow mononuclear cells. J Vasc Surg 2008; 48: 53S-60S; discussion S.
12. Kim DI, Kim MJ, Joh JH, Shin SW, Do YS, Moon JY, et al. Angiogenesis facilitated by autologous whole bone marrow stem cell transplantation for Buerger's disease. Stem Cells 2006; 24: 1194-1200 (Pubitemid 44464687)
13. Shi Q, Rafii S, Wu MH, Wijelath ES, Yu C, Ishida A, et al. Evidence for circulating bone marrow-derived endothelial cells. Blood 1998; 92: 362-367 (Pubitemid 28323695)
14. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995; 1: 27-31.
15. Shalaby F, Rossant J, Yamaguchi TP, Gertsenstein M, Wu XF, Breitman ML, et al. Failure of blood-island formation and vasculo-genesis in Flk-1-deficient mice. Nature 1995; 376: 62-66
16. Hristov M, Erl W, Weber PC. Endothelial progenitor cells: mobilization, differentiation, and homing. Arterioscler Thromb Vasc Biol 2003; 23: 1185-1189 (Pubitemid 36871271)
17. Deliliers GL, Caneva L, Fumiatti R, Servida F, Rebulla P, Lecchi L, et al. Ultrastructural features of CD34+ hematopoietic progenitor cells from bone marrow, peripheral blood and umbilical cord blood. Leuk Lymphoma 2001; 42: 699-708. (Pubitemid 32782778)
18. Erl W, Hristov M, Neureuter M, Yan ZQ, Hansson GK, Weber PC. HMG-CoA reductase inhibitors induce apoptosis in neointima-derived vascular smooth muscle cells. Atherosclerosis 2003; 169: 251-258 (Pubitemid 37297471)
19. Harraz M, Jiao C, Hanlon HD, Hartley RS, Schatteman GC. CD34-blood-derived human endothelial cell progenitors. Stem Cells 2001; 19: 304-312 (Pubitemid 32721097)
20. Hristov M, Erl W, Weber PC. Endothelial progenitor cells: isolation and characterization. Trends Cardiovasc Med 2003; 13: 201-206 (Pubitemid 36802024)
21. Kaushal S, Amiel GE, Guleserian KJ, Shapira OM, Perry T, Sutherland FW, et al. Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo. Nat Med 2001; 7: 1035-1040 (Pubitemid 32937384)
22. Quirici N, Soligo D, Caneva L, Servida F, Bossolasco P, Deliliers GL. Differentiation and expansion of endothelial cells from human bone marrow CD133(+) cells. Br J Haematol 2001; 115: 186-194 (Pubitemid 32995115)
23. Schmeisser A, Garlichs CD, Zhang H, Eskafi S, Graffy C, Ludwig J, et al. Monocytes coexpress endothelial and macrophagocytic lineage markers and form cord-like structures in Matrigel under angiogenic conditions. Cardiovasc Res 2001; 49: 671-680 (Pubitemid 32146430)
24. Soligo D, Servida F, Delia D, Fontanella E, Lamorte G, Caneva L, et al. The apoptogenic response of human myeloid leukaemia cell lines and of normal and malignant haematopoietic progenitor cells to the proteasome inhibitor PSI. Br J Haematol 2001; 113: 126-135 (Pubitemid 32423313)
25. Vosseler CA, Erl W, Weber PC. Structural requirements of cyclopentenone prostaglandins to induce endothelial cell apoptosis. Biochem Biophys Res Commun 2003; 307: 322-326 (Pubitemid 36818872)
26. Zernecke A, Erl W, Fraemohs L, Lietz M, Weber C. Suppression of endothelial adhesion molecule up-regulation with cyclopentenone prostaglandins is dissociated from IkappaB-alpha kinase inhibition and cell death induction. FASEB J 2003; 17: 1099-1101
27. Zhao Y, Glesne D, Huberman E. A human peripheral blood monocyte-derived subset acts as pluripotent stem cells. Proc Natl Acad Sci USA 2003; 100: 2426-2431 (Pubitemid 36297515)
28. Shiba Y, Takahashi M, Hata T, Murayama H, Morimoto H, Ise H, et al. Bone marrow CXCR4 induction by cultivation enhances therapeutic angiogenesis. Cardiovasc Res 2009; 81: 169-177
29. Tateno K, Minamino T, Toko H, Akazawa H, Shimizu N, Takeda S, et al. Critical roles of muscle-secreted angiogenic factors in therapeutic neovascularization. Circ Res 2006; 98: 1194-1202 (Pubitemid 43948106)
30. Kudo FA, Nishibe T, Nishibe M, Yasuda K. Autologous transplantation of peripheral blood endothelial progenitor cells (CD34+) for therapeutic angiogenesis in patients with critical limb ischemia. Int Angiol 2003; 22: 344-348 (Pubitemid 38324801)
31. Kawamura A, Horie T, Tsuda I, Abe Y, Yamada M, Egawa H, et al. Clinical study of therapeutic angiogenesis by autologous peripheral blood stem cell (PBSC) transplantation in 92 patients with critically ischemic limbs. J Artif Organs 2006; 9: 226-233 (Pubitemid 44954312)
32. Wigley FM. Vascular disease in scleroderma. Clin Rev Allergy Immunol 2009; 36: 150-175
33. Chung L, Fiorentino D. Digital ulcers in patients with systemic sclerosis. Autoimmun Rev 2006; 5: 125-128 (Pubitemid 43129542)
34. Drenkard C, Villa AR, Reyes E, Abello M, Alarcon-Segovia D. Vasculitis in systemic lupus erythematosus. Lupus 1997; 6: 235-42.
35. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999; 340: 115-126
36. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002; 105: 1135-1143
37. Kuwana M, Okazaki Y, Yasuoka H, Kawakami Y, Ikeda Y. Defective vasculogenesis in systemic sclerosis. Lancet 2004; 364: 603-610
38. Del Papa N, Quirici N, Soligo D, Scavullo C, Cortiana M, Borsotti C, et al. Bone marrow endothelial progenitors are defective in systemic sclerosis. Arthritis Rheum 2006; 54: 2605-2615 (Pubitemid 44205023)
39. Gomer RH. Circulating progenitor cells and scleroderma. Curr Rheumatol Rep 2008; 10: 183-188
40. Distler JH, Allanore Y, Avouac J, Giacomelli R, Guiducci S, Moritz F, et al. EULAR Scleroderma Trials and Research group statement and recommendations on endothelial precursor cells. Ann Rheum Dis 2009; 68: 163-168
41. Westerweel PE, Luijten RK, Hoefer IE, Koomans HA, Derksen RH, Verhaar MC. Haematopoietic and endothelial progenitor cells are deficient in quiescent systemic lupus erythematosus. Ann Rheum Dis 2007; 66: 865-870
42. Moonen JR, de Leeuw K, van Seijen XJ, Kallenberg CG, van Luyn MJ, Bijl M, et al. Reduced number and impaired function of circulating progenitor cells in patients with systemic lupus erythematosus. Arthritis Res Ther 2007; 9: R84. (Pubitemid 47517251)
43. Grisar J, Steiner CW, Bonelli M, Karonitsch T, Schwarzinger I, Weigel G, et al. Systemic lupus erythematosus patients exhibit functional deficiencies of endothelial progenitor cells. Rheumatology (Oxford) 2008; 47: 1476-1483 (Pubitemid 351876312)
44. Denny MF, Thacker S, Mehta H, Somers EC, Dodick T, Barrat FJ, et al. Interferon-alpha promotes abnormal vasculogenesis in lupus: a potential pathway for premature atherosclerosis. Blood 2007; 110: 2907-2915 (Pubitemid 350006944)
45. Lee PY, Li Y, Richards HB, Chan FS, Zhuang H, Narain S, et al. Type I interferon as a novel risk factor for endothelial progenitor cell depletion and endothelial dysfunction in systemic lupus erythematosus. Arthritis Rheum 2007; 56: 3759-3769 (Pubitemid 350100709)
46. Grisar J, Aletaha D, Steiner CW, Kapral T, Steiner S, Seidinger D, et al. Depletion of endothelial progenitor cells in the peripheral blood of patients with rheumatoid arthritis. Circulation 2005; 111: 204-211 (Pubitemid 40139733)
47. Jaff MR. Thromboangiitis Obliterans (Buerger's Disease). Curr Treat Options Cardiovasc Med 2000; 2: 205-212
48. Takahashi M, Ishigatsubo Y, Fujimoto K, Miyamoto M, Horie T, Aizawa Y, et al. Autologous mononuclear cell implantation therapy for critical digit ischemia in patients with connective tissue diseases. Circulation 2008; 118: S-906 (No.4535).
49. Nevskaya T, Ananieva L, Bykovskaia S, Eremin I, Karandashov E, Khrennikov J, et al. Autologous progenitor cell implantation as a novel therapeutic intervention for ischaemic digits in systemic sclerosis. Rheumatology (Oxford) 2009; 48: 61-64
50. Kamata Y, Takahashi Y, Iwamoto M, Matsui K, Murakami Y, Muroi K, et al. Local implantation of autologous mononuclear cells from bone marrow and peripheral blood for treatment of ischaemic digits in patients with connective tissue diseases. Rheumatology (Oxford) 2007; 46: 882-884 (Pubitemid 47061726)
51. Miyamoto K, Nishigami K, Nagaya N, Akutsu K, Chiku M, Kamei M, et al. Unblinded pilot study of autologous transplantation of bone marrow mononuclear cells in patients with thromboangiitis obliterans. Circulation 2006; 114: 2679-2684 (Pubitemid 44967352)
52. Grisar J, Aletaha D, Steiner CW, Kapral T, Steiner S, Saemann M, et al. Endothelial progenitor cells in active rheumatoid arthritis: effects of tumour necrosis factor and glucocorticoid therapy. Ann Rheum Dis 2007; 66: 1284-1288 (Pubitemid 47492469)
53. Barsotti MC, Di Stefano R, Spontoni P, Chimenti D, Balbarini A. Role of endothelial progenitor cell mobilization after percutaneous angioplasty procedure. Curr Pharm Des 2009; 15(10): 1107-1122
54. Uchida C, Haas TL. Evolving strategies in manipulating VEGF/VEGFR signaling for the promotion of angiogenesis in ischemic muscle. Curr Pharm Des 2009; 15(4): 411-421
55. Vannini N, Pfeffer U, Lorusso G, Noonan DM, Albini A. Endothelial cell aging and apoptosis in prevention and disease: E-selectin expression and modulation as a model. Curr Pharm Des 2008; 14(3): 221-225